Convertino, Irma
Cazzato, Massimiliano
Giometto, Sabrina
Gini, Rosa
Valdiserra, Giulia
Cappello, Emiliano
Ferraro, Sara
Tillati, Silvia
Bartolini, Claudia
Paoletti, Olga
Lorenzoni, Valentina
Trieste, Leopoldo
Filippi, Matteo
Turchetti, Giuseppe
Cristofano, Michele
Blandizzi, Corrado
Mosca, Marta
Lucenteforte, Ersilia
Tuccori, Marco
Article History
Received: 24 March 2021
Accepted: 23 August 2021
First Online: 13 October 2021
Competing interests
: IC, SF, GV, EC, MT, CB, EL, SG, VL, LT, GT are involved as investigators of observational studies funded by pharmaceutical companies (e.g. Galapagos) in compliance with the ENCEPP code of conduct. RG, CB, OP are employed by ARS, a public health agency that conducts or participates in pharmacoepidemiology studies compliant with the ENCePP Code of Conduct. The budget of ARS is partially sustained by such studies. MM has carried out consultancy/conference presentations for ABBVIE, LILLY, UCB, GSK, BMS. MC, ST, MF, MC have no relevant financial or non-financial interests to disclose.